thalidomide has been researched along with Respiratory Distress Syndrome in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rocco, PR | 1 |
| Momesso, DP | 1 |
| Figueira, RC | 1 |
| Ferreira, HC | 1 |
| Cadete, RA | 1 |
| Légora-Machado, A | 1 |
| Koatz, VL | 1 |
| Lima, LM | 1 |
| Barreiro, EJ | 1 |
| Zin, WA | 1 |
1 trial available for thalidomide and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury.
Topics: Analysis of Variance; Animals; Bronchoalveolar Lavage Fluid; Lipopolysaccharides; Mice; Mice, Inbred | 2003 |